A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence

Addiction

Volumn 101, Issue 11, 2006, Pages 1656-1661

  Kaper, J ^a   Wagena, E J ^b   Willemsen, M C ^c   Van Schayck, C P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Pulmonary Rehabilitation Centre Hornerheide   (Netherlands)

^c STIVORO for a Smoke free Future   (Netherlands)

Author keywords

Prolonged abstinence; Reimbursement; Smoking cessation treatment

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PATIENT INFORMATION; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; SELF REPORT; SMOKING; SMOKING CESSATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTIVATION; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 33749528190     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01578.x     Document Type: Article

References (22)

1. Edwards R. ABC of smoking cessation. The problem of tobacco smoking. BMJ 2004; 328: 217-9.
2. Xu X., Dockery D. W., Ware J. H., Speizer F. E., Ferris B. G. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992; 146: 1345-8.
3. Anthonisen N. R., Connett J. E., Kiley J. P., Altose M. D., Bailey W. C., Buist A. S. et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-505.
4. Fiore M. C., Bailey W. C., Cohen S. J., Dorfman S. F., Goldstein M. G., Gritz E. R. et al. Treating tobacco use and dependence. Clinical Practical Guideline. Rockville, MD: US Department of Health and Human Services; 2000.
5. West R., McNeill A., Raw M. Smoking cessation guidelines for health professionals: an update. Thorax 2000; 55: 987-99.
6. Zhu S., Melcer T., Sun J., Rosbrook B., Pierce J. Smoking cessation with and without assistance. A population-based analysis. Am J Prev Med 2000; 18: 305-11.
7. Kaper J., Wagena E. J., Willemsen M. C., Van Schayck C. P. Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction 2005; 100: 1012-20.
8. Fagerstrom K., Schneider N. Measuring nicotine dependence; a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989; 12: 159-82.
9. Jarvis M., Tunstall-Pedoe H., Feyerabend C., Vesey C., Saloojee Y. Comparison of tests used to distinguish smokers from non-smokers. Am J Public Health 1987; 77: 1435-8.
10. Boyle R. G., Solberg L. I., Magnan S., Davidson G., Alesci N. L. Does insurance coverage for drug therapy affect smoking cessation? Health Affairs 2002; 21: 162-8.
11. McMenamin S., Halpin H. A., Ibrahim J. K., Orleans C. T. Physician and enrollee knowledge of Medicaid coverage for tobacco dependence treatment. Am J Prev Med 2004; 26: 99-104.
12. Burns M. E., Rosenberg M. A., Fiore M. Use of a new comprehensive insurance benefit for smoking-cessation treatment. Prev Chronic Dis Public Health Res Pract Policy 2005;2: 1-12.
13. Murphy J. M., Shelly D., Repetto P. M., Cummings K. M., Mahoney M. C. Impact of economic policies on reducing tobacco use among Medicaid clients in New York. Prev Med 2003; 37: 68-70.
14. Hughes J. R., Wadland W. C., Fenwick J. W., Lewis J., Bickel W. K. Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study. Prev Med 1991; 20: 486-96.
15. Schauffler H. H., McMenamin S., Olson K., Boyce Smith G., Rideout J. A., Kamil J. Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial. Tob Control 2001; 10: 175-80.
16. Kaper J., Wagena E. J., Severens J. L., van Schayck C. P. Healthcare financing systems for increasing the utilisation of smoking cessation treatment [Cochrane Review]. In: The Cochrane Library , Issue 1. Oxford: Update Software; 2005.
17. Curry S. J., Grothaus L. C., McAfee T., Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med 1998; 339: 673-9.
18. Silagy C., Stead L. F. Physician advice for smoking cessation [Cochrane Review]. In: The Cochrane Library . Oxford: Update Software; 2004. Issue 1.
19. Hughes J. R., Stead L. F., Lancaster T. Antidepressants for smoking cessation. In: The Cochrane Library , Issue 1. Oxford: Update Software; 2004.
20. Lancaster T., Stead L. F. Individual behavioural counselling for smoking cessation. In: The Cochrane Library , Issue 1. Oxford: Update Software; 2004.
21. Silagy C., Lancaster T., Stead L., Mant D., Fowler G. Nicotine replacement therapy for smoking cessation. In: The Cochrane Library, Issue 1. Oxford: Update Software; 2004.
22. Kaper J., Wagena E. J., van Schayck C. P., Severens J. L. Encouraging smokers to quit: the cost-effectiveness of reimbursing the costs of smoking cessation treatment. Pharmacoeconomics 2006; 24: 453-64.